联仁健康成立于2019年11月，是由国家卫生健康委员会部署、中国移动牵头组建的健康医疗大数据公司。

联仁健康是由“央企领投，地方政府、金融机构与医疗信息化企业共同参与，以国资为主体并具备市场化机制”的健康医疗大数据公司，由中国移动牵头组建，太平洋保险、济南国际医学中心产业发展有限公司、浦东投控科创基金等7家公司共同参与，实缴注册资本20亿元，是健康医疗大数据领域的“生力军”。

联仁健康践行国家“新基建”和“要素市场化配置”战略，以医疗大数据汇聚运营与核心科研能力为基础，聚焦医疗信息化科技与医疗服务运营，构建医疗健康数据产业闭环，赋能“三医联动”新型医疗服务体系转型。

联仁健康正与医疗行业各机构、产业合作伙伴开展广泛合作，共同建设健康医疗大数据生态圈，推动形成健康医疗服务新模式、新业态，全力以赴助力建设“健康中国”。

Lianren Health was established in November 2019 and is a healthcare big data company deployed by the National Health Commission and led by China Mobile.

Lianren Health is a health and medical big data company led by central enterprises, with the participation of local governments, financial institutions, and medical informatization enterprises, with state-owned assets as the main body and market-oriented mechanisms. It was established under the leadership of China Mobile, with seven companies including Pacific Insurance, Jinan International Medical Center Industrial Development Co., Ltd., and Pudong Investment Control Science and Technology Innovation Fund participating. The registered capital paid in is 2 billion yuan, It is a "new force" in the field of healthcare big data.

Lianren Health practices the national strategy of "new infrastructure" and "market-oriented allocation of factors", based on the convergence and operation of medical big data and core scientific research capabilities, focusing on medical information technology and medical service operation, constructing a closed-loop medical and health data industry, and empowering the transformation of the "three medical linkage" new medical service system.

Lianren Health is conducting extensive cooperation with various institutions and industry partners in the medical industry to jointly build a health and healthcare big data ecosystem, promote the formation of new models and formats of health and healthcare services, and fully contribute to the construction of "Healthy China".